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Abstract
Background: Health disparities are a growing concern. Recently, we conducted a practice-based
trial to help primary care physicians improve adherence with 21 quality indicators relevant to the
primary and secondary prevention of cardiovascular disease and stroke. Although the primary
concern in that study was whether patients in intervention practices outperformed those in control
practices, we were also interested in determining whether minority patients were more, less, or
just as likely to benefit from the intervention as non-minorities.
Methods: Baseline (fourth quarter 2000) and follow-up (fourth quarter 2002) data were obtained
from 3 intervention practices believed to have at least 10% minority representation. Two practices
had a black (non-Hispanic) population sufficient for analysis, while the other had a sufficient
Hispanic population. Within each practice, changes in the 21 indicators were compared between
the minority patient population and the entire patient population. The proportion of measures in
which minority patients exhibited greater improvement was calculated for each practice and for all
3 practices combined, and comparisons were made using non-parametric methods.
Results: For all black patients, the observed improvement in 50% of 22 eligible study indicators
was better than that observed among all white patients in the same practices. The average changes
in the study indicators observed among the black and white patients were not significantly different
(p = 0.300) from one another. Likewise for all minority patients in all 3 practices combined, the
observed improvement in 14 of 29 (43.3%) eligible study indicators was better than that observed
among all white patients. The average changes in the study indicators among all minority patients
were not significantly different from the changes observed among the white patients (p = 0.272).
Conclusions: Among 3 intervention practices involved in a quality improvement project, there did
not appear to be any significant disparity between minority and non-minority patients in the
improvement in study indicators.
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Introduction
In 2002, the Institute of Medicine (IOM) issued a report
suggesting that minorities are more likely than non-
minorities to receive a lower quality of healthcare [1].
Because of the issues such as those raised in the IOM
report, health disparities are a growing concern. This con-
cern is reflected in many ways, including the development
by National Institutes of Health of a program of action to
confront these disparities and the Healthy People 2010
goal of eliminating these disparities.
Disparities are particularly evident in the area of chronic
diseases. Although blacks are more likely than whites to
have blood pressure monitoring, cholesterol screening,
and smoking counseling, coronary heart disease is more
prevalent among blacks than among whites [2]. Addition-
ally, among all ethnic groups, blacks experience the high-
est mortality rates associated with heart disease, cancer,
cerebrovascular disease, and HIV/AIDS. Although the
overall mortality rate among blacks has been declining
over the past 50 years, rates for cancer and diabetes were
actually higher in 1995 than in 1950. On a similar note,
Hispanics are significantly more likely as non-Hispanic
whites to die from diabetes and HIV/AIDS [3].
In hopes of improving health outcomes and prevention
practices for all patients, much focus has recently been
given towards the improvement in quality of healthcare.
For example, the 7th report of the Joint National Commit-
tee on Prevention, Detection, Evaluation, and Treatment
of High Blood Pressure outlines specific guidelines for
preventing and managing hypertension, hyperlipidemia,
and coronary heart disease [4]. The 2nd report of the
National Cholesterol Education Program (NCEP) expert
panel on detection, evaluation, and treatment of high
blood cholesterol in adults makes specific recommenda-
tions on the prevention and care of hyperlipidemia and
coronary heart disease [5]. Other quality indicators also
exist for the prevention and management of other chronic
diseases, including heart failure, atrial fibrillation, and
diabetes, diseases which were all targeted in the current
study.
Recently, there have also been a number of practice-based
interventions aimed at improving the quality of health-
care for patients. For example, researchers have shown
that a practice-based intervention (the Healthy Steps for
Young Children Program) can enhance the quality of care
for families of young children [6]. Additionally, a practice-
based telephone intervention was proven to improve
pneumococcal vaccine immunization for seniors [7]. We
have also reported on a practice-based intervention to
help primary care physicians improve adherence with 21
quality indicators relevant to the primary and secondary
prevention of cardiovascular disease and stroke [8,9].
What these earlier interventions have lacked, however, are
analyses examining whether the interventions have
improved the quality of care for all patients, regardless of
ethnicity. Because these types of interventions are heavily
dependent on physician and/or clinical staff interaction
with patients, because ethnic minorities may have less
trust in their healthcare providers [10], and because barri-
ers in the patient physician relationship may contribute to
the ethnic disparities in the quality of the healthcare expe-
rience [11], there exists the possibility that poor cultural
competency could result in a lack of effectiveness of the
intervention among ethnic minorities. If such quality
improvement efforts do not improve care for all ethnic
groups equally, then there may be significant healthcare
policy implications related to the refinement of existing
interventions and to the development of future
interventions.
The aim of this study was to examine whether or not a
multi-method quality improvement (QI) intervention
was equally successful among patients of different ethnic-
ities. Some of the findings from this QI intervention have
been previously published [8,12], and they suggest that
primary care practices that use electronic medical records
and receive regular performance reports can improve their
adherence with clinical practice guidelines for cardiovas-
cular disease and stroke prevention.
Methods
The multi-method QI intervention added practice site vis-
its (for academic detailing and QI facilitation) and net-
work meetings (for sharing of best practices) to the
approach of guideline dissemination and audit and feed-
back, employed in a less intensive intervention. Ten sites
received the intensive multi-method QI intervention, and
ten sites received the less intensive intervention. The study
was conducted in a practice-based research network (PPR-
Net) among users of a common electronic medical record
(Practice Partner Patient Records, Seattle WA), which his-
torically provided audit and feedback to its practice
members.
As a supplement to the original study, we were also inter-
ested in whether minority patients were more, less, or just
as likely to benefit from the intervention as non-minori-
ties. The study presented here focused on outcome and
process measures for minorities within 3 primary care
practices, all of which received the intensive intervention.
These 3 practices (labeled A, B, and C) were selected
because they each had a significant (i.e. > 10%) propor-
tion of minority patients and had recorded patient ethnic-
ity in their electronic medical record. Practice A is an
urban internal medicine practice in the Midwestern U.S.
with 5 healthcare providers. Practice B is a rural family
medicine practice in the Northeastern U.S. with 8International Journal for Equity in Health 2004, 3:12 http://www.equityhealthj.com/content/3/1/12
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healthcare providers. Practice C is an urban family medi-
cine practice in the Southeastern U.S.
A total of 21 study indicators (see Table 1) were obtained
from each practice at baseline (fourth quarter 2000) and
at the end of the study (fourth quarter 2002). These indi-
cators were derived from published sources [4,5,13-16]
and were deemed to be the most appropriate indicators
for measuring quality of prevention and management of
cardiovascular disease and stroke. Fourteen of the study
indicators are process measures, reflecting whether recom-
mended tests were done, appropriate diagnoses made or
medication prescribed. Seven indicators are outcome
measures, reflecting whether patients achieved recom-
mended treatment goals. Some of the measures represent
primary prevention, e.g., screening for hypertension or
hyperlipidemia. Others represent secondary prevention,
e.g., reaching treatment goals for glycosylated hemo-
globin, low-density lipoprotein (LDL) cholesterol, and
blood pressure in patients with diabetes. The institutional
Table 1: Study indicators
CONDITION MEASURES
Hypertension1 Process measures:
• BP measurement in prior 12 months
• Diagnosis of hypertension for 3 measurements >= 140/90 in prior 12 months
• BP measurement in prior 3 months for patients with diagnosis of hypertension
Outcome measures:
• Most recent BP measurement < 140/90 for all patients
• Most recent BP measurements < 140/90 for patients with diagnosis of hypertension
Hyperlipidemia (General Population screening)2 Process measures:
• Measure of total cholesterol in prior 36 months
• Measure of HDL-C in prior 36 months
Coronary Heart Disease 1,2,3 Process measures:
• Measurement of LDL-cholesterol in prior 12 months
• Recorded diagnosis of hyperlipidemia for LDL-cholesterol > 130 mg/dl
• Medication for hyperlipidemia for LDL-cholesterol > 130 mg/dl
• Prescription of beta-blocker in patients with history of myocardial infarction
Outcome measures:
• Most recent LDL-cholesterol < 100 mg/dl
• Most recent BP measurement < 140/90
Heart Failure4 Process measure:
• Prescription of angiotensin converting enzyme inhibitor or angiotensin receptor blocker
Atrial Fibrillation5 Process measure:
• Prescription of oral anticoagulant
Diabetes Mellitus6 Process measures:
• Measurement of glycosylated hemoglobin in prior 12 months
• Measurement of LDL-cholesterol in prior 24 months
• BP measurement in prior 3 months
Outcome measures:
• Most recent glycosylated hemoglobin < 7 %
• Most recent LDL-cholesterol < 100 mg/dl
• Most recent BP measurement < 130/85
1 Adapted from The Sixth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC VI). 
National Institute of Health, National Blood Pressure Education Program, NIH publication 98-4080, November 1997.
2 Adapted from Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and 
Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993; 269(23): 301523.
3 Adapted from American Heart Association Scientific Statement: Smith SC, Blair SN, Criqui MH, etal: Preventing Heart Attack and Death in 
Patients with Coronary Disease. Circulation. 1995;92:2–4. Although the AHA recommendation is to measure total cholesterol at least every 60 
months, we were forced to restrict our measure to 36 months due to restrictions of the historical data.
4 Adapted from American Heart Association Scientific Statement: Williams JF, Bristow MR, Fowler MB, etal: Guidelines for the Evaluation and 
Management of Heart Failure. Circulation. 1995;92:2764–2784
5 Adapted from American Heart Association Scientific Statement: Prystowsky EN, Benson DW, Fuster, V, etal: Management of Patients with Atrial 
Fibrillation. Circulation 1996;93:1262–1277.
6 Adapted from American Diabetes Association, Diabetes Quality Improvement Project, Initial Measure Set (Final Version) August 14, 1998International Journal for Equity in Health 2004, 3:12 http://www.equityhealthj.com/content/3/1/12
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review board at the Medical University of South Carolina
approved the study.
To determine practice performance on the study indica-
tors, participating practices ran a computer program to
extract patient activity during the previous quarter from
their electronic medical record. To protect patient confi-
dentiality, the extract program assigned an anonymous
numerical identifier unique to each patient. The extract
program obtained demographic information such as age,
ethnicity, and gender, and diagnoses, medications, labo-
ratory data, and vital signs. Text of consultation reports,
progress notes, and discharge summaries were not
extracted. The data were copied to diskettes and mailed to
PPRNet or sent electronically via a secure server. In the
PPRNet offices, data were bridged to standard data dic-
tionaries and converted to SAS® (Statistical Analysis Sys-
tem, Cary NC) data sets on standard microcomputers for
analyses.
In each patient's electronic medical record, ethnicity was
recorded as white, black/African American, American
Indian/Alaskan native, Asian, native Hawaiian/other
Pacific islander, and "some other ethnicity", while ethnic-
ity was recorded as Hispanic/Latino and non-Hispanic/
Latino, all in concordance with the 2000 U.S. Census eth-
nicity categories. Currently, these physician practices
allow the patient to designate their ethnicity categoriza-
tion. However, because this process for collecting ethnic-
ity data began in the middle of our study, some ethnicity
categorizations were made by the office staff within each
of the practices. Ethnicity data was only available on
approximately 42% of patients, due to the fact that the
electronic medical record software program did not
require physicians to enter patients' ethnicity data until its
most recent version was released, which occurred during
the study time frame. Improvements in process and out-
come measures were compared between minority and
non-minority patients. Minority was defined as any ethnic
designation other than white non-Hispanic.
Changes in the process and outcome measures were of
primary interest in this study. Within each practice, these
changes were compared between the minority patient
population and the white patient population. Measures
were deemed eligible for comparison if at least 10 minor-
ity patients were included in the rate calculations. For
example, if practice A only had 8 minority patients with a
diagnosis of having had myocardial infarction (MI), then
the measure of the percentage of MI patients who had
been prescribed a beta blocker could not be compared
between the minority and white patient population. The
proportion of eligible measures in which minority
patients exhibited greater improvement was calculated for
each practice and for all 3 practices combined. A Wilcoxon
signed rank test (the non-parametric equivalent of the
paired t-test) was used to test the hypotheses that minority
patients exhibited changes similar to those of the non-
minority patients. This study had approximately 80%
power (2-sided hypothesis testing, α = 0.05) to detect a
6.6 percentage point difference between average improve-
ment in the study indicators among all minority and non-
minority patients.
Results
Baseline characteristics of the patients from the 3 practices
are listed in table 2. In practice A, black (non-Hispanic)
patients were the only sizable minority. Although practice
Table 2: Baseline characteristics of the patients within the 3 practices of interest
Characteristic Practice A Practice B Practice C
Black patients 
(n = 179)
White patients 
(n = 1,079)
Hispanic patients 
(n = 254)
White patients 
(n = 2,526)
Black patients 
(n = 117)
White patients 
(n = 491)
Demographics
Age (mean ± s.d.) 54.2 ± 15.2**** 60.7 ± 17.8 34.5 ± 17.9 33.7 ± 18.9 42.0 ± 16.7*** 51.2 ± 16.9
Gender (% female) 68.7 69.2 46.1*** 57.9 67.5* 56.4
Medical conditions
Hypertension (%) 50.8 51.1 7.1 7.8 21.4 21.0
Hyperlipidemia (%) 33.5*** 47.5 5.5 4.1 0.9* 5.3
Diabetes (%) 12.9 9.7 4.3* 2.0 12.0 7.5
Coronary disease (%) 7.8 11.7 1.2 1.0 0.0 0.0
Heart failure (%) 2.2 4.9 0.0 0.2 1.7 0.6
Atrial fibrillation (%) 1.1 3.9 0.0 0.1 0.0 0.2
* p < 0.05 when compared to white patients within the particular practice
** p < 0.01 when compared to white patients within the particular practice
*** p < 0.001 when compared to white patients within the particular practice
**** p < 0.0001 when compared to white patients within the particular practiceInternational Journal for Equity in Health 2004, 3:12 http://www.equityhealthj.com/content/3/1/12
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B did contain 10 black non-Hispanic patients, this sample
was not large enough for substantive comparisons. There
were enough Hispanic patients in Practice B to compare
with the entire groups of patients within that practice. In
practice C, there were 117 black patients used for compar-
ison. There were several significant differences of note
between the minority patients to the overall population of
patients within that same practice. Compared to the white
patient population in practice A, the minority patients
were significantly younger and significantly less likely to
be diagnosed with hyperlipidemia. Compared to the
white patient population in practice B, the minority
patients were significantly more likely to be male and to
have diabetes. In practice C, the minority patients were
significantly younger, more likely to be female, and less
likely to have a diagnosis of hyperlipidemia.
Additional file 1 lists the baseline and end-of-study meas-
urements for each of the 21 study indicators, for minority
patients and white patients within each of the 3 practices.
In practice A, the improvement in 7 of 16 eligible study
indicators was better among black patients than among
white patients in that practice. (For 9 of these 16 indica-
tors, the improvement was worse among the black
patients.) In practice B, the improvement in 3 of 7 eligible
study indicators was better among Hispanic patients than
among white patients in that practice, and worse for 4 of
the 7 indicators. In practice C, the improvement in 4 of 6
eligible study indicators was better among black patients
than among white patients in that practice. Thus for all
black patients in practices A and C, the observed improve-
ment in 11 of 22 (50.0%) eligible study indicators was
better than that observed among white patients. On aver-
age, indicators improved 4.4 and 9.3 percentage points
among black and white patients, respectively. These
changes were not significantly different (p = 0.300) from
one another. Likewise for all minority patients in all 3
practices combined, the observed improvement in 14 of
29 (48.3%) eligible study indicators was better than that
observed among non-minority (white) patients. On aver-
age, indicators improved 4.6 and 8.3 percentage points
among minority and non-minority patients, respectively,
and these changes were not significantly different (p =
0.272) from one another.
Discussion
In these 3 physician practices, all of which were in the
intervention arm of a randomized trial aimed at improv-
ing primary and secondary prevention of cardiovascular
disease and stroke, we found that results for minorities
were relatively similar to the results experienced by the
overall practice populations. Change from baseline was
greater among minority patients than among white
patients for 48.3% of the 29 eligible study indicators, and
the average changes in the study indicators among all
minority patients were not significantly different from the
changes observed among the white patients.
There are some limitations of this study which should be
noted. As noted earlier, the ethnicity status was only avail-
able on 42% of patients within the practices of interest;
thus the results may not truly represent what occurred in
these practices overall during the study. Given the rela-
tively small number of eligible indicators for comparisons
across ethnicities, this statistical power to detect subtle dif-
ferences was not optimal. Nevertheless, the overall find-
ings suggest that any true differences in this intervention's
effectiveness across ethnicities are small.
These findings are encouraging, and they suggest that the
quality improvement strategies that have been developed
to date for physician practices that use electronic medical
records have a similar impact on minorities and non-
minorities. Future studies should continue to address
whether the effectiveness of interventions such as ours is
cross-cultural, and whether interventions tailored to be
more culturally appropriate can improve the overall effec-
tiveness of interventions.
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